PREVIEW
The enormous number of articles in the medical literature on prevention of coronary artery disease and cancer reflects the variety of proposed prophylactic approaches and the quantity of investigation. In this article, Dr Lush discusses agents currently in use, citing only randomized trials done in healthy people with primary prevention established as a principal end point.